Home > Journals > Minerva Anestesiologica > Past Issues > Minerva Anestesiologica 2017 April;83(4) > Minerva Anestesiologica 2017 April;83(4):392-401

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as

 

REVIEW   Freefree

Minerva Anestesiologica 2017 April;83(4):392-401

DOI: 10.23736/S0375-9393.16.11545-7

Copyright © 2016 EDIZIONI MINERVA MEDICA

language: English

Clinical indices and biomarkers for perioperative cardiac risk stratification: an update

Radmilo J., JANKOVIĆ 1, 2, Danica Z. MARKOVIĆ 2, Dušan T. SOKOLOVIĆ 3, Ivana ZDRAVKOVIĆ 4, Massimiliano SORBELLO 5

1 Department of Anesthesiology and Intensive Care, School of Medicine, University of Niš, Niš, Serbia; 2 Center for Anesthesiology and Reanimatology, Clinical Center of Niš, Niš, Serbia; 3 Department of Biochemistry, School of Medicine, University in Niš, Niš, Serbia; 4 Department of Anesthesiology and Reanimatology, Clinical Hospital Center ”Zvezdara“, Belgrade, Serbia; 5 Department of Anesthesia and Intensive Care, Vittorio Emanuele Policlinic, Catania, Italy


PDF


European Society of Cardiology (ESC)/ European Society of Anesthesiology (ESA) highlighted that anesthesiologist has a leading role in perioperative cardiovascular assessment and management in the year of 2014. During cardiovascular assessment one can rely on cooperation of multidisciplinary specialists like: other anesthesiologists, cardiologists and surgeons. For the purpose of precise systematization and decision making the Lee Score or NSQUIP database can be used besides the traditionally used ASA Score. Additional help is provided with specific palette of cardiac biomarkers like: cardiac troponins T, cardiac troponins I, C-reactive protein, N-terminal pro-brain natriuretic peptide, brain natriuretic peptide, etc. Biomarkers are considered to represent a foundation of evidence based medicine and they help anesthesiologists in the decision-making process. They increase the chance to achieve the best clinical outcome for each patient. An ideal biomarker does not exist and therefore new research are currently being conducted with the aim to find and declare more specific biomarkers like heart-type fatty acid-binding protein, micro RNA, PAMP and high sensitivity troponins T.


KEY WORDS: Biomarkers - MicroRNAs - Mid-regional pro-adrenomedullin, human - FABP3 protein, human

top of page